Pharmacoeconomic analysis of the treatment of multiple actinic keratoses

Journal of Drugs in Dermatology

Volumn 7, Issue 1, 2008, Pages 23-25

  Gold, Michael H ^a,b,c  

^a GOLD SKIN CARE CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOQUINOLINE DERIVATIVE; DICLOFENAC; FLUOROURACIL; IMIQUIMOD;

ARTICLE; CRYOTHERAPY; ECONOMICS; HUMAN; KERATOSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

AMINOLEVULINIC ACID; AMINOQUINOLINES; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; CRYOTHERAPY; DICLOFENAC; FLUOROURACIL; HUMANS; KERATOSIS; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 42149139587     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cockerell CJ, Wharton JR. New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J Drugs Dermatol. 2005;4:462-467.
2. Gold MH. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging. Cutis. 2002;69(6 suppl):S8-S13.
3. Nestor M, Gold M, Kauvar A, et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol. 2006;5:140-154.
4. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol. 2007;56:125-143. (Pubitemid 44969292)
5. Centers for Medicare and Medicaid Services. Hospital Outpatient (HOPPS) 2007 April Update. Available at: http://www.cms.hhs.gov/HospitalOutpatientPPS/ AU/itemdetail.asp?filterType=none&filter-ByDID=-99&sortByDID= 1&sortOrder=descending&itemID= CMS1197965&intNumPerPage=10%20. Accessed May 29, 2007.
6. Centers for Medicare and Medicaid Services. Physician fee schedule (MFPS) 2007 Final Rule. Available at: http://www.cms.hhs.gov/PhysicianFeeSched/ PFSNPAF/itemdetail.asp?filterType=none&filterByDID=-99&sortByDID= 2&sortOrder=ascending&itemID= CMS1196563&intNumPerPage=10. Accessed May 29, 2007.
7. Fleming T, ed. Red Book 2007: Pharmacy's Fundamental Reference. Philadelphia, PA; Thomson PDR; 2007.
8. Levulan® Kerastick® [package insert]. Wilmington, MA. Dusa Pharmaceuticals.
9. Efudex® [package insert]. Costa Mesa, CA: Valeant Pharmaceuticals North America
10. Aldara™ Cream, 5% [package insert]. St. Paul, MN: 3M Pharmaceuticals.
11. Solaraze™ Gel [package insert]. Malvern, PA: Bioglan Pharmaceuticals Company